US Stock MarketDetailed Quotes

AVTX Avalo Therapeutics

Watchlist

9.5400
-0.5900-5.82%

Close Oct 11 16:00 ET

9.5400
0.00000.00%

Post 20:01 ET

92.54MMarket Cap0.05P/E (TTM)

Avalo Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Avalo Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q4	-- / 0.000	--
--	2024/Q3	-- / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--
--	2023/Q4	571.000K / 300.000K	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q4-- / 0.000--

--2024/Q3-- / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

--2023/Q4571.000K / 300.000K--

Unlock Free Earnings Estimates

Open Account

Avalo Therapeutics Earnings Reports

Avalo Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 12 07:05 ET

Avalo Therapeutics | 10-Q/A: Quarterly report (Amendment)

Jul 11 16:20 ET

Avalo Therapeutics | 10-Q: Q1 2024 Earnings Report

May 13 07:34 ET

Avalo Therapeutics | 10-K: FY2023 Annual Report

Mar 29 16:08 ET

Analyst Rating

Updated: Jun 30, 2024

Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall